Cinnamon and Systemic lupus erythematosus - a phase IV clinical study of FDA data
Systemic lupus erythematosus is found among people who take Cinnamon, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Cinnamon and have Systemic lupus erythematosus. It is created by eHealthMe based on reports of 3,735 people who have side effects when taking Cinnamon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,735 people reported to have side effects when taking Cinnamon.
Among them, 11 people (0.29%) have Systemic lupus erythematosus.
What is Cinnamon?
Cinnamon has active ingredients of cassia cinnamon. It is often used in diabetes. eHealthMe is studying from 3,700 Cinnamon users for its effectiveness, alternative drugs and more.
What is Systemic lupus erythematosus?
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,308 drugs and 1,570 conditions by eHealthMe.
Number of Cinnamon and Systemic lupus erythematosus reports submitted per year:
Gender of people who have Systemic lupus erythematosus when taking Cinnamon *:
- female: 100 %
- male: 0.0 %
Age of people who have Systemic lupus erythematosus when taking Cinnamon *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 30 %
- 60+: 70 %
Common drugs people take besides Cinnamon *:
- Vitamin B12: 9 people, 81.82%
- Vitamin E: 7 people, 63.64%
- Prednisone: 5 people, 45.45%
- Fish Oil: 4 people, 36.36%
- Vitamin D3: 4 people, 36.36%
- Glucosamine: 3 people, 27.27%
- Mobic: 3 people, 27.27%
- Qvar: 3 people, 27.27%
- Phrenilin: 3 people, 27.27%
- Norvasc: 3 people, 27.27%
Common side effects people have besides Systemic lupus erythematosus *:
- Memory Loss: 5 people, 45.45%
- Pain: 5 people, 45.45%
- Drug Hypersensitivity: 4 people, 36.36%
- Nasopharyngitis (inflammation of the nasopharynx): 4 people, 36.36%
- Malaise (a feeling of general discomfort or uneasiness): 4 people, 36.36%
- Breathing Difficulty: 4 people, 36.36%
- Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 27.27%
- Head Banging (violently shaking the head in time with the music): 3 people, 27.27%
- Microcytic Anaemia (a generic term for any type of anaemia characterized by small red blood cells): 3 people, 27.27%
- Head Injury: 3 people, 27.27%
Common conditions people have *:
- Hair Loss: 5 people, 45.45%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 36.36%
- Immune System Disorder: 4 people, 36.36%
- Weakness: 3 people, 27.27%
- Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 27.27%
- Gout (uric acid crystals building up in the body): 3 people, 27.27%
- Neuropathy Peripheral (surface nerve damage): 3 people, 27.27%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 27.27%
- Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 27.27%
- Gait Disturbance: 3 people, 27.27%
* Approximation only. Some reports may have incomplete information.
Do you take Cinnamon and have Systemic lupus erythematosus?Check whether Systemic lupus erythematosus is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How severe was Systemic lupus erythematosus and when was it recovered:
Expand to all the drugs that have ingredients of cassia cinnamon:
Alternative drugs to, pros and cons of Cinnamon:
- Cinnamon (3,700 reports)
Common Cinnamon side effects:
- Fatigue (feeling of tiredness): 323 reports
- Drug ineffective: 246 reports
- Diarrhea: 244 reports
- Headache (pain in head): 236 reports
- Dizziness: 212 reports
- Pain: 185 reports
- Weakness: 173 reports
Browse all side effects of Cinnamon:a b c d e f g h i j k l m n o p q r s t u v w x y z
Systemic lupus erythematosus treatments and more:
- Systemic lupus erythematosus (62,017 reports)
COVID vaccines that are related to Systemic lupus erythematosus:
- Systemic lupus erythematosus in Moderna COVID Vaccine
- Systemic lupus erythematosus in Pfizer BioNTech Covid Vaccine
- Systemic lupus erythematosus in Johnson and Johnson Covid Vaccine
Common drugs associated with Systemic lupus erythematosus:
- Humira: 10,390 reports
- Prednisone: 9,611 reports
- Methotrexate: 9,255 reports
- Remicade: 8,872 reports
- Enbrel: 8,359 reports
- Orencia: 7,533 reports
- Cimzia: 7,105 reports
- Arava: 7,038 reports
- Actemra: 6,809 reports
- Sulfasalazine: 6,540 reports
All the drugs that are associated with Systemic lupus erythematosus:
- Systemic lupus erythematosus (2,308 drugs)
Common conditions associated with Systemic lupus erythematosus:
- Rheumatoid arthritis: 10,615 reports
- Crohn's disease: 1,998 reports
- Psoriasis: 1,457 reports
- Multiple sclerosis: 823 reports
- High blood pressure: 742 reports
All the conditions that are associated with Systemic lupus erythematosus:
- Systemic lupus erythematosus (1,570 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cassia cinnamon (the active ingredients of Cinnamon) and Cinnamon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xalatan and Apathy - a second ago
- Proair Hfa and Erythema Nodosum - 9 seconds ago
- Voltaren vs. Cataflam - 11 seconds ago
- Toviaz and Forced Expiratory Volume Decreased - 11 seconds ago
- Fluconazole and Mucosal Discoloration - 12 seconds ago
- Digoxin and Idhifa drug interaction - 17 seconds ago
- Etodolac and Feldene drug interaction - 22 seconds ago
- Ritalin and Peripheral Swelling - 23 seconds ago
- Propecia and Eye Movements - Uncontrollable - 26 seconds ago
- Vagifem and Pain Of Skin - 32 seconds ago